PCa screening can pose difficulties due to the limits of prostate-specific antigen (PSA) testing which, though widely spread and useful in early detection, can produce a considerable number of false positives, being also elevated in non-cancerous conditions, including prostatitis, benign prostatic hyperplasia, and urinary tract infections [15]. The gene discussed is KLK3; the disease is urogenital neoplasm.